Chiesi Brazil

Last updated: 13.02.2014

Address: Rua Giacomo Chiesi, 151, km 39,2 Estrada dos Romeiros Santana de Parnaíba – SP CEP: 06500-970,Brazil

Tel: 11 4622-8500

Web: http://www.chiesi.com.br/

Company description

The Chiesi Group, an ethical pharmaceutical company, with more than 75 years dedicated to research and development of new medicines and technologies, is today one of the leading pharmaceutical companies in Europe, with an extensive line of products in various therapeutic segments.
Based in Parma, Italy, the group operates in all continents with 22 direct branches, three production plants (Italy, France and Brazil) and four research and development centers for new products and technologies (Italy, France, USA and England).
The Chiesi Brazil subsidiary has been responsible for operations in Brazil since 1976, offering healthcare professionals and patients, drugs with the quality and reliability are recognized around the world.

Chiesi Brazil provides important resources for the drug therapy of diseases related to various specialties such as respiratory diseases (asthma and chronic obstructive pulmonary disease), allergic diseases (rhinitis and urticaria), cardiovascular (hypertension and angina), metabolic disorders (dyslipidemia), muscle skeletal Poliaminoacids and supplements.

In addition Chiesi Brazil develops technologies that make life easier for patients, such as inhalers and spacers for the administration of drugs used by inhalation. In this area, the Chiesi Group has developed a new technology called Modulite ®, making medicinal aerosols which are free of substances harmful to the ozone layer, and consequently, environment friendly.

Chiesi Brazil has also developed the use of tobramycin for inhalation, used for the treatment of lung infections present in patients with cystic fibrosis.

Products and services

Modulite, respiratory diseases (asthma and chronic obstructive pulmonary disease), allergic diseases (rhinitis and urticaria), cardiovascular (hypertension and angina), metabolic disorders (dyslipidemia), musculo-skeletal, Poliaminoacids and supplements.

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here